Improving Provider Counseling Interventions in HIV Practice - Full Text View

Sponsors and Collaborators:	Johns Hopkins University University of California, San Francisco
Information provided by:	Johns Hopkins University
ClinicalTrials.gov Identifier:	NCT00538993

Purpose

Hypothesis: HIV clinicians trained to deliver brief counseling messages and receiving cues from a brief computer survey on risk behaviors of their patients can counsel have an impact on patient's risk behaviors.

Condition	Intervention
HIV Infections	Behavioral: Stage based counseling

Study Type:	Interventional
Study Design:	Health Services Research, Randomized, Open Label, Parallel Assignment

Resource links provided by NLM:

MedlinePlus related topics: AIDS

U.S. FDA Resources

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:

Disclosure of HIV status to sex partners; unprotected sexual encounters. [ Time Frame: 12 months ]

Estimated Enrollment:	425
Study Start Date:	September 2003
Estimated Study Completion Date:	October 2007

Arms	Assigned Interventions
1: Experimental Provider receives cue sheet to assist with counseling.	Behavioral: Stage based counseling
2: No Intervention Provider does not receive cue sheet.

Detailed Description:

This is a randomized controlled study. The purpose of this study is to assess the impact of the cue sheet as an aid to targeted provider behavioral counseling. All enrolled participants are HIV+ adults seen for regular medical care at a site affiliated with the Johns Hopkins AIDS Service. After consenting, participants will take an audio-assisted computer interviews to collect patient risk assessment data. For participants randomized to the intervention arm, the printed output on risk behaviors is then given to the provider along with cues for staged-based counseling for use during the same visit. Participants in the control arm take the same computerized risk assessment but there are no printed cue sheets. Risk behaviors of all participants are assessed at entry, at 6 months, and at 12 months. The main outcome measure is change in HIV transmission behaviors at 12 months for those in the intervention arm compared to the control arm.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

HIV seropositive
English speaking

Exclusion Criteria:

Cannot give informed consent

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00538993

Locations

United States, Maryland
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21205

Sponsors and Collaborators

Johns Hopkins University

University of California, San Francisco

Investigators

Principal Investigator:

Emily Erbelding, M.D.

Johns Hopkins University

More Information

No publications provided

Study ID Numbers:	H97HA01144
Study First Received:	October 1, 2007
Last Updated:	October 1, 2007
ClinicalTrials.gov Identifier:	NCT00538993 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases

Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:

Virus Diseases
Sexually Transmitted Diseases, Viral
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
HIV Infections

Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Infection
Retroviridae Infections
Immunologic Deficiency Syndromes

ClinicalTrials.gov processed this record on September 11, 2009